Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Alivus Life Sciences Ltd.	Balance Sheet

NSE: ALIVUSEQ BSE: 543322ISIN: INE03Q201024INDUSTRY: Pharmaceuticals

BSE

Rs 987.40

Open: 950.65

Today's Range 950.65

1011.85

NSE
Rs 986.70
+21.00 (+ 2.13 %)

+20.45 (+ 2.07 %)

Prev Close: 966.95

52 Week Range 827.10

1335.00

You can view the Balance Sheet for the last 5 years.

Market Cap. (Rs.)	12104.97 Cr.	P/BV	4.77	Book Value (Rs.)	206.92
52 Week High/Low (Rs.)	1335/850	FV/ML	2/1	P/E(X)	24.93
Bookclosure	17/10/2023	EPS (Rs.)	39.58	Div Yield (%)	0.00

(Rs. in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00
No. of Equity Shares (in Lacs)	1225.35	1225.27	1225.27	1225.27	98.00

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	24.51	24.51	24.51	24.51	1.96
Total Share Capital	24.51	24.51	24.51	24.51	1.96

Reserves and Surplus	2792.87	2307.82	2107.02	2026.31	750.79
Total Reserves and Surplus	2792.87	2307.82	2107.02	2026.31	750.79
Employees Stock Options	0.00	0.00	6.68	3.50	0.00
Total Shareholders Funds	2817.37	2332.32	2138.21	2054.31	752.75

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	54.43	48.79	42.43	31.50	22.89
Other Long Term Liabilities	50.96	14.76	17.09	1.20	0.00
Long Term Provisions	18.54	15.77	0.00	0.00	0.00
Total Non-Current Liabilities	123.92	79.32	59.53	32.70	22.89

CURRENT LIABILITIES
Trade Payables	390.46	368.66	396.56	307.72	221.31
Other Current Liabilities	62.74	58.08	92.32	61.84	980.23
Short Term Provisions	16.96	12.03	15.54	14.44	19.90
Total Current Liabilities	470.16	438.77	504.41	384.00	1221.44

Total Capital And Liabilities	3411.45	2850.41	2702.15	2471.01	1997.08

ASSETS
NON-CURRENT ASSETS
Tangible Assets	950.33	795.01	774.89	584.65	564.89
Intangible Assets	12.28	10.05	5.74	10.38	7.91
Capital Work-In-Progress	94.25	101.19	49.35	91.69	14.10
Intangible Assets Under Development	0.00	4.80	12.26	0.00	0.00
Fixed Assets	1056.86	911.05	842.25	686.72	586.90
Non-Current Investments	0.08	0.08	0.08	0.08	0.08
Other Non-Current Assets	19.36	23.29	9.49	19.63	11.06
Total Non-Current Assets	1076.30	934.41	851.81	706.42	598.03


CURRENT ASSETS
Current Investments	477.62	0.00	0.00	0.00	0.00
Inventories	673.95	666.59	604.17	516.24	513.42
Trade Receivables	969.74	765.43	806.77	673.49	619.50
Cash And Cash Equivalents	71.24	301.59	309.40	512.16	115.60
OtherCurrentAssets	142.62	182.38	130.01	62.69	150.52
Total Current Assets	2335.16	1916.00	1850.34	1764.58	1399.04

Total Assets	3411.45	2850.41	2702.15	2471.01	1997.08

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	34.20	12.83	50.42	17.23

BONUS DETAILS
Bonus Equity Share Capital	0.00	19.60	19.60	19.60	0.00

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00	0.08	0.08	0.08	0.08

Market

Derivatives

Mutual Fund

IPO

Quick Links

Alivus Life Sciences Ltd.

Balance Sheet